10 reports of this reaction
2.3% of all ARTICAINE HYDROCHLORIDE AND EPINEPHRINE reports
#7 most reported adverse reaction
CARDIAC ARREST is the #7 most commonly reported adverse reaction for ARTICAINE HYDROCHLORIDE AND EPINEPHRINE, manufactured by Benco Dental. There are 10 FDA adverse event reports linking ARTICAINE HYDROCHLORIDE AND EPINEPHRINE to CARDIAC ARREST. This represents approximately 2.3% of all 433 adverse event reports for this drug.
Patients taking ARTICAINE HYDROCHLORIDE AND EPINEPHRINE who experience cardiac arrest should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
CARDIAC ARREST is a less commonly reported adverse event for ARTICAINE HYDROCHLORIDE AND EPINEPHRINE, but still significant enough to appear in the safety profile.
In addition to cardiac arrest, the following adverse reactions have been reported for ARTICAINE HYDROCHLORIDE AND EPINEPHRINE:
The following drugs have also been linked to cardiac arrest in FDA adverse event reports:
CARDIAC ARREST has been reported as an adverse event in 10 FDA reports for ARTICAINE HYDROCHLORIDE AND EPINEPHRINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
CARDIAC ARREST accounts for approximately 2.3% of all adverse event reports for ARTICAINE HYDROCHLORIDE AND EPINEPHRINE, making it a notable side effect.
If you experience cardiac arrest while taking ARTICAINE HYDROCHLORIDE AND EPINEPHRINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.